Predict your next investment

Avion Pharmaceuticals company logo
HEALTHCARE | Pharmaceuticals / Drugs
avionrx.com

See what CB Insights has to offer

Founded Year

2011

About Avion Pharmaceuticals

Avion Pharmaceuticals is a specialty pharmaceutical company that develops and markets a portfolio of branded prescription pharmaceutical and dietary supplement products in women's health, hematology, dermatology, and related specialties.

Avion Pharmaceuticals Headquarter Location

1880 McFarland Parkway Suite 110-B

Alpharetta, Georgia, 30005,

United States

888-612-8466

Latest Avion Pharmaceuticals News

ImmuPharma partner makes headway with US FDA

Jun 24, 2021

Avion Pharmaceuticals has been granted what’s called a Type C meeting with the Food & Drug Administration ImmuPharma PLC (LON:IMM, Euronext Growth Brussels:ALIMM) said its US partner received a positive response from the American drug regulator ahead of a pharmacokinetic (PK) assessment of its lupus treatment. Avion Pharmaceuticals was granted what’s called a Type C meeting with the Food & Drug Administration which will allow the watchdog to “review the proposed methodology” of the PK study. It was requested as part of the new optimised international phase III trial of Lupuzor, the ImmuPharma-developed treatment for systemic lupus erythematosus, a potentially life-threatening autoimmune disease. A response from the FDA is expected around the end of next month. Tim Franklin, ImmuPharma’s chief operating officer, said: "We continue to acknowledge the FDA's support following constructive meetings and feedback this year with our partner Avion. “ImmuPharma and Avion are fully committed to commencing the Lupuzor phase III trial in Lupus patients this year. “Again, we reiterate Lupuzor's unique mechanism of action and robust safety profile to date, which we believe will position Lupuzor as a first-line therapy to many Lupus sufferers globally." Quick facts: ImmuPharma PLC

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Avion Pharmaceuticals Patents

Avion Pharmaceuticals has filed 2 patents.

The 3 most popular patent topics include:

  • Analgesics
  • Anticonvulsants
  • Beta blockers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/18/2019

6/15/2021

Beta blockers, Phenols, Analgesics, Opioid antagonists, Morphinans

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/18/2019

00/00/0000

Grant Date

6/15/2021

00/00/0000

Title

Subscribe to see more

Related Topics

Beta blockers, Phenols, Analgesics, Opioid antagonists, Morphinans

Subscribe to see more

Status

Grant

Subscribe to see more

Avion Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Avion Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.